Life Sciences Archives - Page 2 of 17 - Becker's Hospital Review

Treatment for rare disease OK'd | Costco to sell Wegovy, Ozempic | Mifepristone approved before shutdown | Surgeons general warn of HHS instability

October 8, 2025 1. FDA approves first new treatment for rare disease in 10 years Full story 2. Costco to sell Wegovy, Ozempic Full story 3. Patient-reported outcomes are powering real-time decisions at Norton and Endeavor. Details here. 4. 'Bigger…

Breast cancer drug approved | Government shutdown: What to know | HHS to speed up gene therapy progress | Breakdown of GLP-1 approvals

October 1, 2025 1. FDA approves breast cancer drug Full story 2. Government shutdown begins: What healthcare leaders should know Full story 3. Labor spend doesn't have to undermine ROI goals. Find a smarter staffing model here. 4. GLP-1 drug…

1st Barth syndrome treatment OK'd | Lilly: New GLP-1 more effective than competitor | 6 drugs in shortage | US weighs visa exemptions for physicians

September 24, 2025 1. Eli Lilly claims its GLP-1 outperforms semaglutide in trial Full story 2. FDA approves 1st Barth syndrome treatment Full story 3. New protocols + EHRs are falling short on inpatient diabetes care. Why and what to…

CDC awards vaccine, autism contract | St. Jude 3D printing drug compounds | Cardiology enters GLP-1 era | MSK to cut 2% of jobs

September 17, 2025 1. CDC to award no-bid contract for vaccine, autism research Full story 2. St. Jude tests 3D printing for drug formulations Full story 3. Too many metrics & not enough progress: Reset your ops strategy with this…

GLP-1s deemed essential | Repurposed drugs target cancer 'sleeper cells' | Novartis inks $1.4B heart drug deal | HHS outlines children's health plan

September 10, 2025 1. Repurposed drugs successfully target cancer 'sleeper cells': 5 study notes Full story 2. WHO adds GLP-1s to essential medications list Full story 3. UCSF Health increased nurse satisfaction + workload equity in infusion. See what drove…

Trump demands COVID data | Pfizer lays off 100 | GLP-1s cut heart failure risks | FDA approves Alzheimer's drug

September 3, 2025 1. Pfizer lays off 100 in Washington state Full story 2. Trump demands COVID 'drug' data from pharmaceutical companies Full story 3. Still waiting for AI results? These 3 case studies show what works. Details here. 4. FDA…

3 new drugs to watch | GLP-1s' impact on cancer care | AbbVie to buy drug for $1.2B | Eli Lilly's GLP-1 cuts weight by 10% | Pharma merger forms $6B company

August 27, 2025 1. GLP-1s and cancer: What to know Full story 2. 3 new drugs to watch: Optum Full story 3. CEOs and CFOs from Cleveland Clinic, Intermountain Health and Geisinger join 375+ speakers dissecting capital allocation, partnership models…

Eli Lilly accused of bribing providers | Wegovy gets OK to treat liver disease | Ozempic price halved | AstraZeneca launches 1st at-home flu shot

August 20, 2025 1. FDA approves Wegovy to treat liver disease Full story 2. Texas accuses Eli Lilly of bribing providers to prescribe Mounjaro, other drugs Full story 3. Build a back office that bends — not breaks — when…

Eli Lilly GLP-1 pill shines in trial | Brain tumor, ketamine drugs approved | GSK gets $370M in patent settlement | FDA vaccine chief returns

August 13, 2025 1. FDA approves brain tumor drug targeting new mutation Full story 2. Eli Lilly's daily GLP-1 pill sheds 27 pounds in trial Full story 3. Underresourced and overburdened: How rural hospitals can better support clinical teams here.…

RFK Jr. cancels $500M in vaccine contracts | Blood cancer therapy denied approval | CMS floats GLP-1 coverage | FDA's top vaccine, gene therapy official resigns

August 6, 2025 1. FDA denies approval for Regeneron blood cancer therapy Full story 2. RFK Jr. cancels $500M in mRNA vaccine contracts Full story 3. Stop overtime creep: Find efficiency tips from Baptist MD Anderson's team here. 4. CMS…